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Lateral diffusiona b s t r a c t
Growing evidence shows that GM1 ganglioside is involved in amyloid deposition and toxicity. By
means of real-time single particle tracking, we show that amyloid oligomers and aggregates formed
by Ab1–42 and amylin, two peptides associated, respectively, with the development of Alzheimer’s
disease and type II diabetes, interact with GM1 and decrease dramatically its lateral diffusion on
the plasma membrane of living neuroblastoma cells. The conﬁnement of GM1, a constituent of
membrane rafts involved in neuroprotection, at the level of both types of amyloid aggregates can
interfere with cell signaling pathways and contribute to the loss of neuroprotection.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Neuronal impairment in Alzheimer’s disease (AD) is currently
attributed to a complex cascade of events triggered by the interac-
tion of amyloid oligomers, constituted primarily by Ab1–42 pep-
tide, with the plasma membrane [1]. Amongst the variety of
toxic mechanisms proposed, one involves the binding of amyloid
species to GM1 gangliosides [2–6]. GM1 takes part into the forma-
tion of membrane rafts, dynamic and specialized membrane
microdomains responsible for the compartmentalization of cellular
processes such as signalling and protein trafﬁcking [7,8]. Altered
distribution of GM1 and GM2 gangliosides has been recently found
in AD brains [9]. The interaction with GM1 has been demonstrated
to be a crucial factor also in mediating the aggregation and toxicity
of other amyloidogenic proteins and peptides [10–12], such as
amylin (also known as human islet polypeptide, hIAPP), whose
aggregation and binding to the plasma membrane is thought to
be the main factor determining the death of pancreatic b-cells in
type II diabetes [13]. In particular, in vitro experiments show thatthe aggregation and seeding of Ab and amylin peptides on syn-
thetic membranes are enhanced in the presence of GM1
[10,14,15], as well as in vivo studies demonstrate increased assem-
bly at the level of membrane rafts [12,16,17]. Conversely, GM1 is
fundamental in mediating the binding of preformed Ab oligomers
and amylin aggregates to synthetic lipid vesicles and causing their
subsequent permeabilitzation [12,18]. Exogenously applied oligo-
meric Ab1–42 has been shown to accumulate on the membrane
of cultured neurons at the level of rafts enriched in GM1 [17]. Nev-
ertheless, experiments providing compelling evidence of interac-
tion between Ab oligomers and GM1 in living cells are still
missing. The consistent, although sometimes conﬂicting, body of
literature on the interaction of GM1 with amyloid species relies
on averaged results obtained using bulk methods. In this case,
many important details can be missed and only the most promi-
nent features are eventually taken into account.
Here we take advantage of single particle tracking (SPT) tech-
niques to monitor in real-time in living cells the dynamics of GM1
following the binding of amyloid aggregates of Ab1–42 and amylin
to the plasma membrane. We demonstrate that a direct interaction
takes place in vivo, heavily affecting the diffusion properties of a
subpopulation of GM1 molecules. Our results might imply an addi-
tional mechanism of toxicity, where amyloid aggregates alter cellu-
lar processes dependent on membrane raft mobility and clustering.
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2.1. Cell culture
Human SH-SY5Y neuroblastoma cells were obtained from
A.T.C.C. (Manassas, VA) and cultured in 1:1 DMEM/F-12 supple-
mented with 10% FBS and 1.0% antibiotics. Cell cultures were main-
tained in a 5.0% CO2 humidiﬁed atmosphere at 37 C and grown
until 80% conﬂuence. Cells were used for a maximum of 20
passages.
2.2. Oligomers preparation and cells treatment
Ab1–42 (A9810) and amylin (D2162) were purchased from Sig-
ma. Amylin or Ab1–42 peptides were initially incubated in hexa-
ﬂuoroisopropanol (HFIP) at room temperature for 1 h. The HFIP
was evaporated under a gentle stream of N2. Dried peptide aliquots
were dissolved in anhydrous DMSO to a ﬁnal concentration of
5.0 mM, diluted into ice-cold phenol red-free F12 medium to
100 lM and incubated at 4 C for 24 h. Ab1–42 and amylin samples
were transferred directly to the cell medium to a ﬁnal concentra-
tion of 10 lM monomer equivalent for 1 h at 37 C.
2.3. Immunolabeling
Following standard protocols, cells previously exposed to amy-
loid aggregates were ﬁxed in 4% paraformaldehyde for 10 min at
room temperature, and then blocked with bovine serum albumin
(BSA, 1 mg/ml, Sigma–Aldrich). Mouse monoclonal anti-Ab
(b-Amyloid DE2B4, Santa Cruz Biotechnology Inc., 1:100 dilution)
and anti-amylin (Amylin R10/99, Santa Cruz Biotechnology Inc.,
1:50 dilution) antibodies were used as primary antibodies
(50 min). Alexa 568 anti-mouse antibodies (Invitrogen) were used
as secondary antibodies at 1:500 dilution (30 min). No labeling
was observed when cells were incubated in the absence of aggre-
gates. GM1 was labeled by incubating cells for 20 min with
10 lg/ml biotinylated ctxb (C9972, Sigma) and subsequentely with
streptavidin-Atto 488 (Atto Tec) at 1:500 dilution (20 min). Finally,
we incubated cover slips for 1 min with 1 lg/ml Hoechst 33342
(Invitrogen). Washing was performed between each step in PBS.
The cover slips were mounted on glass microscope slides with a
Mowiol 4-88 solution (9% Mowiol w/w, 22.7% glycerol w/w,
0.2 M Tris–HCl, pH 8.5, 3 mM NaN3.
Cells were monitored with a Nikon Eclipse TE300 inverted
microscope equipped with a Nikon Plan-Apo 60XA/1.40 n.a. DICH
WD 0.21 oil immersion objective. Excitation light was provided
by a mercury lamp (Hg 100W). Fluorescence signal was detected
by a Hamamatsu Photonics K.K. Japan high sensitivity silicon-
intensiﬁed target (SIT) camera, coupled to a Hamamatsu Argus Im-
age Processor and a Hamamatsu C2400 camera controller. Digital
images were captured using a custom-made Virtual Instrument
on Labview 7.1.
2.4. PLA
In situ Proximity Ligation Assay (PLA) was performed with Duo-
link kit (Olink, Bioscience) with minor modiﬁcations at the level of
primary antibody labeling. Basically, two primary antibodies raised
in different species recognize the target antigen or antigens of
interest. Species-speciﬁc secondary antibodies, called PLA probes,
each with a unique short DNA strand attached to it, bind to the pri-
mary antibodies. When the PLA probes are in close proximity
(<40 nm), the DNA strands can interact through a subsequent addi-
tion of two other circle-forming DNA oligonucleotides. After join-
ing of the two added oligonucleotides by enzymatic ligation, theyare ampliﬁed via rolling circle ampliﬁcation using a polymerase.
After the ampliﬁcation reaction, several-hundredfold replication
of the DNA circle has occurred, and labeled complementary oligo-
nucleotide probes highlight the product. The resulting high con-
centration of ﬂuorescence in each single-molecule ampliﬁcation
product is easily visible as a distinct bright dot. Here, cells previ-
ously exposed to amyloid aggregates were ﬁxed following the pro-
tocol above and incubated with anti-Ab1–42 or anti-amylin (1:100
or 1:50, respectively) for 20 min, and anti-mouse PLA probe.
Regarding the anti-rabbit PLA probe the labeling procedure was
more elaborated but still feasible. Cells were incubated for
10 min with 10 lg/ml biotinylated ctxb, subsequentely with
10 lg/ml streptavidin (Invitrogen) for 1 min, with biotinylated
anti-rabbit Fab antibodies (1:400, Abcam) for 15 min, then with a
randomly chosen rabbit antibody (in this case we used anti-hypf-
N, 1:100), and ﬁnally with the anti-rabbit PLA probe.
2.5. Single particle imaging and tracking
Quantum dots (QDs) labeling and live imaging has been exten-
sively described in [19]. Brieﬂy, living cells previously exposed to
amyloid aggregates were incubated in phenol red-free Leibovitz’s
L-15 medium 10% FBS at 37 C ﬁrst with anti-Ab1–42 or anti-amy-
lin (1:100 or 1:50, respectively) for 20 min, then for 5 min with
anti-mouse Alexa 488 (1:500) and 10 lg/ml biotinylated ctxb,
and ﬁnally with streptavidin QDs (Invitrogen) in QD binding buffer
for 1 min. QDs emitting at 655 nmwere used at a 1:10000 dilution.
Cells were monitored with a custom-made wide-ﬁeld epiﬂuores-
cence microscope equipped with an oil-immersion objective (Ni-
kon Plan Apo TIRF 60/1.45), a Reliant 150 Select argon ion laser
(excitation line 488 nm) and a heating chamber. A FF499-Di01-
25 dichroic, and FF01-655/15-25 (for QDs) and FF01-530/43-25
(for Alexa 488) emission ﬁlters (Semrock) were used. 250 or 100
consecutive frames were acquired with an integration time of
330 ms, respectively, with an Electron Multiplying Charge-Coupled
device camera PI-Max (Roper Scientiﬁc) using WinView (PI Acton,
Roper Scientiﬁc). Recording sessions did not last more than 30 min.
Tracking of single QDs, which were identiﬁed by their ﬂuores-
cence intermittence, was performed with MATLAB (MathWorks,
Natick, MA) using a homemade macro that accounts for blinking
in the ﬂuorescence signal [19–21]. In brief, the method consisted
of two main steps, applied successively to each frame of the se-
quence. First, ﬂuorescent spots were detected by cross-correlating
the image with a Gaussian model of the Point Spread Function. A
least-squares Gaussian ﬁt was applied (around the local maximum
above a threshold) to determine the center of each spot with a spa-
tial accuracy of 10–20 nm (depending on the signal-to-noise ratio).
Second, QD trajectories were assembled automatically by linking,
from frame to frame, the centres of the ﬂuorescent spots likely
coming from the same QD. The association criterion was based
on the assumption of free Brownian diffusion and took into ac-
count short blinking events. After completion of the process, a
manual association step was performed, in which QD trajectories
of maximal length were assembled from smaller fragments sepa-
rated by longer blinking events that were not taken into account
by the automatic linking procedure. A high concentration of penta-
valent B subunit of cholera toxin can in principle induce crosslink-
ing of GM1 [22]. For SPT experiments, however, we incubated the
cells with ctxb for times shorter than for standard immunolabeling
experiments, thus obtaining a lower level of labeling. The concen-
tration of strep-QDs was largely in excess with respect of biotin-
ctxb. Most if not all the ctxb molecules bound to the plasma mem-
brane are therefore expected to be labeled. In our analysis we only
monitored the dynamics of all the blinking QDs, indicative of
single, not crosslinked, ctxb molecules, and avoided permanently
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GM1.
2.6. Quantitative analysis of diffusion coefﬁcient
The mean square displacement (MSD) analysis allows to calcu-
late the initial diffusion coefﬁcient (D) of each particle [19,21].
Brieﬂy, physical parameters can be extracted from each trajectory
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where xi and yi are the coordinates of a particle on frame i, dt is the
time between two successive frames, N the total number of frames
of the trajectory and ndt the time interval over which the displace-
ment is averaged. This function enables the analysis of the lateral
dynamics on short (initial diffusion coefﬁcient) and long (types of
motion) time scales. Different types of motion can be distinguished
from the time dependence of the MSD [23]. The initial diffusion
coefﬁcient (D) is determined by ﬁtting the initial 2–5 points of
the MSD against time plot with MSD(t) = 4D2–5 t + b. The cumulative
probability C(d) of D deﬁnes the probability that D is less that d. We
compared cumulative probability distributions and median instead
of mean values because D values were spread over four orders of
magnitude.
Images were thresholded with ImageJ software, creating binary
masks corresponding to amyloid aggregates.
2.7. Position vector analysis
The position vector (r) is deﬁned as:
ri ¼ x2i þ y2i
 1=22.8. Statistical analysis
Comparisons between the different cumulative distributions
were performed by Kolmogorov–Smirnov test. A P value <0.05
was considered statistically signiﬁcant. SPT data (52 > n > 370, for
each condition) were collected from more than 10 cells from at
least three independent experiments.
3. Results
3.1. Co-localization of GM1 and amyloid aggregates
The protocol used in this study has been largely used and leads
the formation of toxic amyloid aggregates conformationally similar
to those found in human AD brains [4,13,24,25]. Under these con-
ditions, Ab1–42 displays mostly an oligomeric conformation, while
amylin form large aggregates in addition to oligomers [25,26]. Fol-
lowing a previous protocol [26], neuroblastoma SH-SY5Y cells
were incubated for 1 h in the presence of 1–10 lM (monomer con-
centration) preformed amyloid aggregates.
We ﬁrst investigated the interaction between pre-aggregated
amylin and GM1 following a standard immunoﬂuorescence proto-
col, where a primary antibody is coupled to a secondary ﬂuores-
cent antibody. Amylin was detected using a primary anti-amylin
antibody and a secondary Alexa 568 antibody, while GM1 mole-
cules were subsequently labeled with the biotinylated cholera tox-
in B subunit (ctxb) and streptavidin Atto-488. As expected, amylin
forms large aggregates and GM1 shows a diffuse pattern (Fig. 1A).
Due to the homogeneous distribution of GM1 molecules it would
be inaccurate to claim, based on these observations, that theseco-localize with amylin aggregates. We therefore performed
in situ Proximity Ligation Assay (PLA), a more stringent method de-
signed to detect the proximity of two distinct target molecules
down to 30–40 nm. Basically, dual recognition of target proteins
by pairs of afﬁnity probes generates an ampliﬁable DNA reporter
molecule that is subsequently labeled and serves as a surrogate
marker for interacting proteins. Single events of proximity are con-
sequently detected as spots. In the case of amylin, the clustering of
the spots was very similar to the shape of ﬂuorescently labeled
amylin aggregates (Fig. 1B), suggesting that the GM1 molecules
are spatially very close to amylin.
In agreement with previous results, Ab1–42 oligomeric species
bound to the plasma membrane were detected as small punctae
following standard indirect immunolabeling with anti-Ab1–42
and anti-mouse Alexa 568 (Fig. 1C). Also in this case, the uniform
distribution of GM1 prevented us to draw any conclusion based
on qualitative co-localization with Ab1–42. By contrast, the PLA
approach allowed us to selectively highlight single events of prox-
imity of GM1 and Ab1–42 molecules (Fig. 1D). The distribution and
shape of the PLA signal reﬂected those of Ab1–42 oligomers labeled
with Alexa 568. The approach based on PLA represents a notable
difference from other previously published papers that rely on
merged images of GM1 and amyloid aggregates immunolabeled
with standard ﬂuorophores to claim an interaction [12,16,17].
These results clearly demonstrate that GM1 and amyloid aggre-
gates formed by amylin and Ab1–42 are located in very close
proximity.
3.2. Single GM1 molecules switch type of motion upon interaction with
amyloid aggregates
GM1 mobility has already been the subject of single particle
tracking experiments (SPT) [27–29]. Its membrane dynamics has
been studied extensively, and therefore we choose to perform
SPT experiments to search for a more direct proof of interaction be-
tween GM1 and amyloid aggregates. Notably, the mobility of GM1
is not inﬂuenced by the size of QDs [27]. At the level of nano-sized
probes, the mobility of membrane proteins is rather dependent on
the membrane viscosity, which is several order of magnitude
greater than that of the extracellular medium [30]. Neuroblastoma
SH-SY5Y cells exposed to amylin aggregates were surface labeled
with biotin cxtb/QDs 655 and anti-amylin/anti-rabbit alexa 488.
During our recordings, we were able to detect real-time changes
in GM1 mobility after interaction with amylin (Fig. 2A–D). We dis-
covered that GM1 molecules moving randomly on the plasma
membrane switched their motion from brownian to conﬁned once
in close proximity of amylin aggregates. This sudden change of
mobility is indicative of interaction, as reported in the case of other
proteins, such as the scaffolding protein gephyrin and the glycine
receptor [31,32].
Switches of motion from brownian to conﬁned were also found
when monitoring single GM1molecules in correspondence of Ab1–
42 oligomers (Fig. 2E–H), which we have previously shown dis-
playing a limited mobility [26].
These results show that a change in dynamic behaviour occurs
when GM1 molecules approach amyloid aggregates.
3.3. Conﬁned mobility of GM1 over amyloid aggregates
GM1 molecules switching type of motion represent rare events.
Most of the molecules observed during each recording session
were found to follow either conﬁned or brownian motion. To quan-
tify to which extent amyloid aggregates could affect the lateral dif-
fusion of GM1 molecules, we compared the diffusion coefﬁcients
(D) of GM1 in the absence and presence of the aggregates
(Fig. 3A and Table 1). The median D value of GM1 in control condi-
Fig. 1. Close proximity of GM1 and amyloid aggregates. Neuroblastoma cells incubated for 1 h with preformed amylin aggregates (A and B) or Ab1–42 oligomers (C and D)
were ﬁxed and labeled with anti-amylin (A) or anti-Ab1–42 (C), respectively, and secondary Alexa 568 conjugated antibodies (red). GM1 was detected using biotin-ctxb
coupled to streptavidin-Atto 488 (A and C, green). The close proximity of amyloid aggregates and GM1 was highlighted by in situ PLA co-localization assay (Duolink), a
technique based on the hybridization of DNA strands from two different speciﬁc probes with circle forming oligonucleotides, rolling circle ampliﬁcation and labeling (B and
D). The spot-like ﬂuorescence signal that is generated is present only if GM1 and amylin aggregates (B), or Ab1–42 oligomers (D), are situated within a theoretical distance of
30–40 nm of each other. Scale bar, 10 lm.
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Fig. 2. Real time changes of GM1 mobility in correspondence of amyloid aggregates. Living neuroblastoma cells incubated for 1 h with preformed amylin aggregates (A–D) or
Ab1–42 oligomers (E–H) were surface labeled with anti-amylin (A) or anti-Ab1–42 (B), respectively, and secondary Alexa 488 conjugated antibodies (green). Single GM1
molecules were detected using biotin-ctxb coupled to streptavidin-QD 655 (A and E, red). (B and F) Magniﬁcation of the white regions in A and E showing the trajectories of
GM1 molecules superimposed to the color intensity map of amyloid aggregates. Scale bar, 1 lm. Position vector (C and G) and MSD (D and H) analysis of the GM1 molecules
indicated by the coloured arrows in A and E. Colors corresponds to changes from Brownian or directed (red) to conﬁned motion (blue) of a GM1 molecule after interaction
with an amyloid aggregate. Orange, control GM1 molecule following typical Brownian motion. The MSD was calculated over the time indicated according to the colors in (C).
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Fig. 3. Amyloid aggregates cause the conﬁnement of a subpopulation of GM1
molecules. (A) The cumulative probability distributions of GM1 diffusion coefﬁ-
cients in cells incubated for 1 h with preformed amylin aggregates (cyan) and Ab1–
42 oligomers (blue) show a decreased mobility as compared to control cells
(orange). (B and C) Example of GM1 trajectories superimposed to binary images of
amylin aggregates in a living neuroblastoma cell labeled with anti-amylin,
secondary Alexa 488 antibodies and biotin-ctxb coupled to streptavidin-QD 655.
Trajectories were classiﬁed as over (green) and apart (purple) from amylin
aggregates. Scale bar, 2 lm. (D and E) Cumulative D values distributions of QD-
coupled GM1 calculated from trajectories located over and apart from amylin
aggregates (D) or Ab1–42 oligomers (E). (F) Schematic representation of amyloid
aggregates affecting the lateral diffusion of GM1 molecules.
Table 1
Amylin aggregates and Ab1–42 oligomers alter the lateral diffusion of GM1-ctxb on
the plasma membrane of SH-SY5Y neuroblastoma cells.
Condition Dmedian (lm2 s1) Dmaxa Pb
GM1-ctxb 2.70  102
GM1-ctxb + amylin tot 2.94  103 4.4  101 6104
GM1-ctxb + Ab1–42 tot 4.17  103 4.1  101 6104
GM1-ctxb + amylin out 1.34  102 3.2  101 6104
GM1-ctxb + amylin over 9.16  104 7.7  101 6104
CTXB + Ab1–42 out 4.78  103 4.0  101 6104
GM1-ctxb + Ab1–42 over 2.49  103 5.1  101 6104
Ab1–42 [26] 6.1  104
a Maximum difference in cumulative fraction between cells incubated with and
without aggregates.
b Kolmogorov–Smirnov test P value calculated using Dmax as statistic.
52 > n > 370.
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previous experiments on GM1-ctxb mobility (1.83  102 lm2 s1
[27], 4.7  102 lm2 s1 [28]). In cells exposed to amylin aggre-
gates or Ab1–42 oligomers the cumulative distributions of D values
appeared to be dramatically different from control experiments
(Fig. 3A). The median D was one order of magnitude lower either
in the presence of amylin aggregates or Ab1–42 oligomers
(Table 1).
Furthermore, when binary masks corresponding to the thres-
holded ﬂuorescently labeled aggregates were used to discriminate
GM1 molecules over and apart from the aggregates (Fig. 3B and C),
the distributions and median D changed even further (Fig. 3D,E and
Table 1). In the case of amylin, the ensemble of molecules localized
over amylin aggregates showed a decrease in median D of two or-
ders of magnitude compared to the median D value of GM1 mole-
cules apart from the aggregates, which in turn resulted to be very
similar to the control. In the case of Ab1–42 the D distributions of
GM1 over and apart from the oligomers appear not to differ signif-
icantly. This result can be explained by the much smaller size of
Ab1–42 oligomers compared to the large amylin aggregates. The
low intensity ﬂuorescence signal coming from these small oligo-
mers might have been indistinguishable from background ﬂuores-
cence, resulting in a biased D values distribution of GM1 molecules
classiﬁed as apart from the oligomers. The median D of GM1 over
Ab1–42 oligomers is close to that found for single Ab oligomers
[26] (Table 1).
These results indicate that a subpopulation of GM1molecules in
contact with amyloid aggregates switches its dynamic behaviour
to a slower regime (Fig. 3F).
4. Discussion
By combining PLA and SPT experiments, we demonstrate that
the changes in mobility of GM1 observed in living cells are effec-
tively a consequence of the interaction with very slow diffusing
amyloid aggregates. Our new ﬁndings based on the localization
of GM1 over and apart from the aggregates provide the rational
to explain previous results showing that the overall diffusion of
GM1 was decreased in cells exposed to aggregates formed by an
amyloidogenic prion protein not associated to any disease [29].
Altogether, these results underline the generic nature of the inter-
action between amyloid species and GM1 gangliosides.
Previous results in ﬁxed cells have suggested that Ab oligomers
can be trafﬁcked on the plasma membrane and accumulate in lipid
rafts [12,17]. Williamsons and co-workers [17] show a higher de-
gree of co-localization of GM1 and exogenously added Ab oligo-
mers after 1 h incubation compared to 1 min, and suggest that
lipid rafts act as sites of Ab accumulation. What we observed with
real time imaging of GM1 indicates however a substantial differ-
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sibly of membrane rafts, as a consequence of their interaction. We
found that GM1 follows the lateral diffusion behaviour of Ab1–42
oligomers [26], not the inverse. Nonetheless, while demonstrating
that GM1 molecules are sequestered by amyloid aggregates, our
results do not exclude further clustering of GM1 and aggregates
at later stages.
Our results give rise to additional considerations. While plasma
membrane permeation and deformation have been the subject of
many studies, impairment and dysfunction caused by changes in
mobility and lateral trafﬁcking of membrane molecules induced
by amyloid aggregates have been poorly investigated. Considering
that amyloids can bind to a large number of biological molecules
that range from glycosaminoglycans and nucleic acids to a variety
of proteins and lipids, the change in membrane dynamics observed
for GM1 may imply that amyloids can potentially harm all those
cellular mechanisms that base their efﬁciency on molecules mobil-
ity. Although here we limited our investigation to GM1, growing
evidence shows that amyloid aggregates can alter the membrane
mobility of a number of proteins and other plasma membrane
components, and lead either to a gain or to a loss of function. For
example, the binding of Sup35 amyloid ﬁbrils to the plasma mem-
brane can possibly cause an accumulation of Fas receptors associ-
ated with GM1 with subsequent activation of extrinsic apoptotic
pathways [29]. On the other hand, sequestration of neurotransmit-
ter receptors, such as the metabotropic glutamate mGluR5, by
Ab1–42 oligomers has been shown to impair intracellular calcium
levels and synaptic network activity [33]. Within this context, an
alteration of GM1 mobility may compromise its regulatory role
in neurodevelopment and neuroprotection [34,35], or inﬂuence
cellular pathways linked to raft dynamics.
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